"a 6 7" Pill Images
The following drug pill images match your search criteria.
GAVISCON 1175
Gaviscon (regular strength)
- Strength
- aluminum hydroxide 80 mg / magnesium trisilicate 20 mg
- Imprint
- GAVISCON 1175
- Color
- White
- Shape
- Round
1 / 3
Loading
Watson 371 25 mg
Loxapine Succinate
- Strength
- 25 mg
- Imprint
- Watson 371 25 mg
- Color
- Green & White
- Shape
- Capsule/Oblong
ADAMAS 170 Logo
1 / 3
Loading
AP7491 250 mg
Cefaclor
- Strength
- 250 mg
- Imprint
- AP7491 250 mg
- Color
- Turquoise & White
- Shape
- Capsule/Oblong
1 / 2
Loading
2871 Logo (Heart)
1 / 4
Loading
Watson 372 50 mg
Loxapine Succinate
- Strength
- 50 mg
- Imprint
- Watson 372 50 mg
- Color
- Blue & White
- Shape
- Capsule/Oblong
1 / 2
Loading
2875 Logo (Heart)
1 / 4
Loading
WATSON 785 5 mg
Chlordiazepoxide Hydrochloride
- Strength
- 5 mg
- Imprint
- WATSON 785 5 mg
- Color
- Green & Yellow
- Shape
- Capsule/Oblong
1 / 2
Loading
barr 90 mg 871
Fluoxetine Hydrochloride Delayed Release (Once-Weekly)
- Strength
- 90 mg
- Imprint
- barr 90 mg 871
- Color
- Green & White
- Shape
- Capsule/Oblong
Logo LANNETT 1742
Phentermine Hydrochloride
- Strength
- 15 mg
- Imprint
- Logo LANNETT 1742
- Color
- Gray / Orange
- Shape
- Capsule/Oblong
GA 473
Norgesic Forte
- Strength
- aspirin 770 mg / caffeine 60 mg / orphenadrine citrate 50 mg
- Imprint
- GA 473
- Color
- Green & White
- Shape
- Capsule/Oblong
1 / 2
Loading
WATSON 787 25mg
Chlordiazepoxide Hydrochloride
- Strength
- 25 mg
- Imprint
- WATSON 787 25mg
- Color
- Green & White
- Shape
- Capsule/Oblong
Logo (Actavis) 227
Oxymorphone Hydrochloride Extended-Release
- Strength
- 5 mg
- Imprint
- Logo (Actavis) 227
- Color
- Pink
- Shape
- Round
ZA-17 5mg
Bromocriptine Mesylate
- Strength
- 5 mg
- Imprint
- ZA-17 5mg
- Color
- Tan & White
- Shape
- Capsule/Oblong
1 / 2
Loading
Logo (Actavis) 347
Morphine Sulfate Extended-Release
- Strength
- 200 mg
- Imprint
- Logo (Actavis) 347
- Color
- Red
- Shape
- Capsule/Oblong
AVINZA 90 mg 507
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.